FMR LLC 13D and 13G filings for Oruka Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-07 11:37 am Purchase | 2024-10-04 | 13G | Oruka Therapeutics, Inc. ORKA | FMR LLC | 5,512,300 15.345% | 5,512,300 (New Position) | Filing |